Shares of Dr Reddy's Labs climbed as much as 4.5 per cent to Rs 2,520, their highest since January 25. The stock posted its biggest intraday percentage gain in nearly one month, and was the top boost on Nifty Pharma index and top percentage gainer on NSE index.
The company’s active pharmaceutical ingredients plant at Srikakulam in Andhra Pradesh has got the establishment inspection report from the US Food and Drug Administration (FDA), indicating closure of audit.
The plant was one of the company’s main production facilities but the output was hit after the regulator had issued a warning over inadequate quality control practices in 2015.
Nearly 2 million shares changed hands, 1.3 times the 30-day average of 918,000.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.